Cambridge Major Laboratories, Inc., Avantium Pharma, Xcelience, LLC, and Beckloff Associates have formed a consortium of expert client-focused companies to launch Chemistry Playbook, a series of proven, modular, expedited CMC solutions designed to accelerate drug development from carbon to commercialization.
Quality can vary across functional business units within larger service providers, but Chemistry Playbook’s consortium model guarantees functional expertise and accountability at every stage. Features and services include Gantt charts and handoffs for individuals or the entire team; and integrated commercial and billing processes to provide natural pull and ease of doing business.
Beckloff Associates (Overland Park, Kan.) offers regulatory oversight; Cambridge Major Laboratories (Germantown, Wisc.) provides API services; Avantium Pharma (Amsterdam, The Netherlands) offers solid state characterization; and Xcelience (Tampa Bay, Fla.) for formulation development expertise.
The consortium launched Chemistry Playbook at a symposium at the headquarters of the Massachusetts Medical Society in Waltham, Mass.
Avantium Pharma’s Vice President Business Development (North America), Andrei Winkler illustrated the advantages of accessing functional expertise across a series of integrated service providers. Beckloff Associates President, Michael Beckloff said, “Innovator companies of all sizes are under pressure to meet critical milestones faster. Execution-based programs can provide significant advantage through time and cost savings.”
This news was featured in Drug Discovery & Development magazine: Vol. 13, No. 3, April 2010, p. 37.
Filed Under: Drug Discovery
